Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 3, 2021 · Filed Oct 22, 2024
An Aldeyra Therapeutics director paid $5.3K out of pocket for Aldeyra Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,291
Shares × reported transaction price
<$25K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
53 days after results of Mar 11, 2021, 3 days before results of May 6, 2021
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.1% | −0.3% | −7.9% |
| 30 days | −18.5% | +1.8% | −20.2% |
| 90 days | −17.1% | +3.4% | −20.5% |
| 180 days | −62.0% | −11.9% | −50.1% |
| 365 days | −12.0% | +14.5% | −26.5% |
Past results only. Not a forecast.
Insider buying
Traded Apr 12, 2023 · filed 559 days later
An Aldeyra Therapeutics director paid $5.2K out of pocket for Aldeyra Therapeutics shares. It was the first purchase in 23 months. Shares held went up 123% with this purchase.
